The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((4-morpholinophenylamino)methyl)isoindoline-1,3-dione ID: ALA1775068
PubChem CID: 2731384
Max Phase: Preclinical
Molecular Formula: C19H19N3O3
Molecular Weight: 337.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1c2ccccc2C(=O)N1CNc1ccc(N2CCOCC2)cc1
Standard InChI: InChI=1S/C19H19N3O3/c23-18-16-3-1-2-4-17(16)19(24)22(18)13-20-14-5-7-15(8-6-14)21-9-11-25-12-10-21/h1-8,20H,9-13H2
Standard InChI Key: NMFDNVJXDZBLQR-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
-4.4406 0.4005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4417 -0.4265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7273 -0.8391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7291 0.8130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0141 0.4041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0092 -0.4265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2177 -0.6785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7333 -0.0036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2256 0.6653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9754 1.4511 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.9583 -1.4612 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9088 0.0012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3244 0.7229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7388 0.0119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5626 0.0164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9715 0.7335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5506 1.4475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7281 1.4395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7938 0.7417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2100 0.0288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0310 0.0327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4419 0.7480 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0257 1.4609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1985 1.4586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5006 0.7181 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 2 0
7 11 2 0
8 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 20 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
16 19 1 0
12 25 1 0
13 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 337.38Molecular Weight (Monoisotopic): 337.1426AlogP: 2.19#Rotatable Bonds: 4Polar Surface Area: 61.88Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.48CX LogP: 2.19CX LogD: 2.19Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.87Np Likeness Score: -1.44
References 1. Lu W, Liu X, Cao X, Xue M, Liu K, Zhao Z, Shen X, Jiang H, Xu Y, Huang J, Li H.. (2011) SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration., 54 (10): [PMID:21488662 ] [10.1021/jm200139j ] 2. Zhou W, Li S, Lu W, Yuan J, Xu Y, Li H, Huang J, Zhao Z. (2016) Isoindole-1,3-dione derivatives as RSK2 inhibitors: synthesis, molecular docking simulation and SAR analysis, 7 (2): [10.1039/C5MD00469A ]